The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes The US Food & Drug Administration......
Till a few years ago, it was a celebrated company; the first homegrown pharmaceutical major to become a multinational and its shares held a promising future. But since January, Ranbaxy......